Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/21788
Title: Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Breast Neoplasms/chemistry/*drug therapy/mortality,Chemotherapy, Adjuvant,Disease-Free Survival,Female,Humans,Immunohistochemistry,Middle Aged,Multivariate Analysis,Prognosis,Receptor, erbB-2/*analysis,Vascular Endothelial Growth Factor A/*analysis
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/21788
ISSN: 0167-6806
Link: http://www.ncbi.nlm.nih.gov/pubmed/16538542
http://www.springerlink.com/content/07x143553035294u/fulltext.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Kostopoulos-2006-Evaluation of the pr.pdf405.8 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons